1.69
Finanzdaten der Processa Pharmaceuticals Inc-Aktie (PCSA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Income/Loss |
29.87%
-2.3361
|
-3.3312 | -3.7019 | -3.4888 | -3.9508 |
| Nonoperating Income/Loss |
-0.9294
|
- | - | - | - |
|
|
3.31%
-3.2655
|
-3.3772 | -3.3589 | -3.4366 | -3.9339 |
| Basic Average Shares |
4.86%
2.7507
|
2.6231 | - | 47.53 | 15.57 |
| Diluted Average Shares |
4.86%
2.7507
|
2.6231 | - | 47.53 | 15.57 |
| Basic Earnings Per Share |
7.75%
-1.19
|
-1.29 | - | -0.07 | -0.25 |
| Diluted Earnings Per Share |
7.75%
-1.19
|
-1.29 | - | -0.07 | -0.25 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):